55 related articles for article (PubMed ID: 17666474)
1. Rate of change and instability in body mass index, insulin resistance, and lipid metabolism as predictors of atherosclerotic vascular disease.
Christen A; Efstathiadou Z; Laspa E; Johnston DG; Godsland IF
J Clin Endocrinol Metab; 2007 Oct; 92(10):3780-7. PubMed ID: 17666474
[TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
Ariza CR; Frati AC; Gómez G; Almazán A
Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk.
Handberg A; Norberg M; Stenlund H; Hallmans G; Attermann J; Eriksson JW
J Clin Endocrinol Metab; 2010 Apr; 95(4):1939-46. PubMed ID: 20139232
[TBL] [Abstract][Full Text] [Related]
4. Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study.
Godsland IF; Bruce R; Jeffs JA; Leyva F; Walton C; Stevenson JC
Int J Cardiol; 2004 Dec; 97(3):543-50. PubMed ID: 15561346
[TBL] [Abstract][Full Text] [Related]
5. Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology.
Godsland IF; Johnston DG
Metabolism; 2008 Sep; 57(9):1190-7. PubMed ID: 18702943
[TBL] [Abstract][Full Text] [Related]
6. Plasma-parathyroid hormone is associated with subclinical and clinical atherosclerotic disease in 2 community-based cohorts.
Hagström E; Michaëlsson K; Melhus H; Hansen T; Ahlström H; Johansson L; Ingelsson E; Sundström J; Lind L; Arnlöv J
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1567-73. PubMed ID: 24626438
[TBL] [Abstract][Full Text] [Related]
7. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease.
Yip J; Facchini FS; Reaven GM
J Clin Endocrinol Metab; 1998 Aug; 83(8):2773-6. PubMed ID: 9709945
[TBL] [Abstract][Full Text] [Related]
8. Association of serum lipid indices with large artery atherosclerotic stroke.
Bang OY; Saver JL; Liebeskind DS; Pineda S; Ovbiagele B
Neurology; 2008 Mar; 70(11):841-7. PubMed ID: 18160673
[TBL] [Abstract][Full Text] [Related]
9. Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men.
Risérus U; Arnlöv J; Berglund L
Diabetes Care; 2007 Nov; 30(11):2928-33. PubMed ID: 17644620
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
[TBL] [Abstract][Full Text] [Related]
11. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
Ovbiagele B; Saver JL; Lynn MJ; Chimowitz M;
Neurology; 2006 May; 66(9):1344-9. PubMed ID: 16682665
[TBL] [Abstract][Full Text] [Related]
12. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
13. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
Shroff R; Kerchner A; Maifeld M; Van Beek EJ; Jagasia D; Dokras A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4609-14. PubMed ID: 17848406
[TBL] [Abstract][Full Text] [Related]
14. [Multivascular atherosclerosis, the Sarajevo Vascular Study].
Dilić M; Pehar S; Terzić O; Kazić S; Mlaco A; Kurcehajić A; Koco D; Kurtalić E; Svrakić S
Med Arh; 2004; 58(2 Suppl 1):9-11. PubMed ID: 15202298
[TBL] [Abstract][Full Text] [Related]
15. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men.
Godsland IF; Rosankiewicz JR; Proudler AJ; Johnston DG
J Clin Endocrinol Metab; 2001 Feb; 86(2):719-23. PubMed ID: 11158036
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
17. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
18. Repeat antenatal steroid exposure and later blood pressure, arterial stiffness, and metabolic profile.
Norberg H; Stålnacke J; Nordenström A; Norman M
J Pediatr; 2013 Sep; 163(3):711-6. PubMed ID: 23651768
[TBL] [Abstract][Full Text] [Related]
19. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]